Reproductive carrier screening in Australia: cost, the Medicare rebate and the 3-gene vs expanded choice.

The standard 3-gene carrier screen (cystic fibrosis, spinal muscular atrophy and fragile X) has attracted a Medicare rebate since November 2023 when your own GP or specialist requests it, once per lifetime. Expanded panels covering hundreds of genes are self-pay and prices vary. KnowLuna's 3-gene screen is self-pay, priced at launch once our laboratory agreement is signed.

What carrier screening is, and who it is for

Most people who carry a gene change for a serious childhood condition have no idea, because carriers are usually healthy. Reproductive carrier screening is a blood test that looks for those gene changes before or early in a pregnancy, when there is time to make decisions. It is a screening test: it tells you about chance, not about whether a particular child will be affected.

RANZCOG recommends that carrier screening is offered to every woman or couple planning a pregnancy, or early in one, regardless of family history, because most babies born with these conditions have parents with no family history at all. Screening is optional, and choosing not to have it is a legitimate decision.

The ideal time is before you start trying, so results are in hand when every option is still open. Results take two to three weeks, so if you are already pregnant, the earlier the better. It pairs naturally with a preconception check.

The 3-gene screen and the Medicare rebate introduced for it

The standard Australian carrier screen looks at three genes linked to the most common serious inherited conditions:

• Cystic fibrosis (CFTR gene), which affects the lungs and digestion
• Spinal muscular atrophy (SMN1 gene), which affects muscle strength and movement
• Fragile X syndrome (FMR1 gene), the most common inherited cause of intellectual disability

Roughly one in twenty people carries a change in at least one of these three genes. Cystic fibrosis and spinal muscular atrophy follow a recessive pattern, so a child is only affected if both parents pass on a changed copy. Fragile X is different: it is carried on the X chromosome, so the mother's result alone determines the chance for a pregnancy.

Since 1 November 2023, the Medicare Benefits Schedule has included items for 3-gene reproductive carrier screening (item 73451, with partner testing under item 73452). To qualify, the test must be requested by your GP or a specialist for someone who is planning a pregnancy or is already pregnant, and it is available once per lifetime. If you are found to be a carrier of cystic fibrosis or spinal muscular atrophy, testing your reproductive partner for the same gene is also rebated. There is no age limit and no family-history requirement.

In practice this means that if cost is the deciding factor, the cheapest route to the 3-gene screen is a conversation with your GP. Some laboratories bulk-bill the rebated test, in which case there is nothing to pay; others charge a gap. Ask before the blood is taken.

Expanded panels: what they add and what they cost

Expanded carrier screening looks at many more genes, commonly several hundred, covering conditions that are individually rare but collectively add up. It is usually offered as a couple-based test where both partners are screened and the report focuses on genes where you both carry a change.

There are genuine trade-offs. An expanded panel finds more carrier couples, but it also produces more results of uncertain meaning and a higher chance of learning something about your own health that you were not looking for. Genetic counselling before and after is strongly recommended.

On cost, expanded panels are not covered by Medicare in any setting and are entirely self-pay. Prices vary widely between providers and depend on the number of genes, whether one partner or both are tested, and whether counselling is included. Ask for the all-in price, including any collection or consultation fee, before you commit.

Option	Genes	Medicare	Typical wait	Best suited to
3-gene screen via GP	CFTR, SMN1, FMR1	Rebate, once per lifetime	2 to 3 weeks	Anyone planning a pregnancy; lowest cost path
3-gene screen via KnowLuna	CFTR, SMN1, FMR1	Self-pay	2 to 3 weeks	Speed, convenience, plain-English explanation, bundling with a preconception check
Expanded panel	Commonly several hundred	Self-pay	3 to 6 weeks	Couples who want the widest net and are comfortable with uncertain results

Ranges vary by laboratory; your report shows the range your lab uses. Typical ranges on this page are drawn from Pathology Tests Explained (RCPA) and the sources listed below.

Turnaround times and rebate rules change; check current information with the laboratory or your doctor.

KnowLuna's 3-gene price and pathway

KnowLuna offers the same 3-gene screen as a self-pay test. It is not rebated by Medicare when ordered this way, so it is not the cheapest route; it is the fastest and simplest one, and the one that comes with a plain-English report and a doctor to explain it.

Option 1: bring a signed request from your own doctor and collect with the home swab or saliva kit we post you, or at an accredited (NATA/RCPA) centre near you if you prefer. Option 2: a KnowLuna women's health doctor reviews a short questionnaire, requests the test, and explains your result in a 20-minute video consult. If a result shows you are a carrier, a doctor contacts you before you read it alone, and genetic counselling is arranged.

Partner testing when one result is positive

For cystic fibrosis and spinal muscular atrophy, a carrier result in one partner is only half the picture. The next step is to test the other partner for the same gene. If they are not a carrier, the chance of an affected child is very low and no further action is usually needed. If both partners are carriers, each pregnancy has a one-in-four chance of an affected child, and a genetic counsellor talks through the options, which can include testing during pregnancy and, for some couples, IVF with embryo testing.

For fragile X, partner testing is not needed, because the chance depends on the mother's result. Women who carry a fragile X premutation are also offered information about their own health, since the premutation can be linked to earlier menopause. When the 3-gene screen is rebated through a GP, the partner's follow-up test is rebated too. Through KnowLuna, a partner test is a separate self-pay order.

What a positive carrier result means

Being a carrier is not a diagnosis, and it is not a health problem. It describes a chance for a future pregnancy, and only becomes relevant when combined with a partner's result (for recessive conditions) or on its own (for fragile X).

A positive result also does not mean a pregnancy is affected. Even when both partners carry a change in the same gene, three in four pregnancies are unaffected. What the result gives you is information and time: to test a partner, to speak to a genetic counsellor, and to decide what, if anything, you want to do with what you learn.

Common questions

Sources and further reading

• Pathology Tests Explained (RCPA): reproductive carrier screening
• Medicare Benefits Schedule: item 73451, reproductive carrier screening (CF, SMA, fragile X)
• Medicare Benefits Schedule: item 73452, reproductive partner carrier testing
• RANZCOG: Genetic carrier screening (statement C-Obs 63)
• Pregnancy, Birth and Baby: genetic carrier screening
• Healthdirect: genetic testing

General information only, not medical advice. If your symptoms are severe or sudden, see a doctor promptly. This page does not replace a consultation with a doctor who knows your history; read our medical disclaimer.